TB-500 operates systemically as a **cytoskeleton remodeler**: its primary function is G-actin monomer sequestration (active N-terminal Ac-Ser-Asp-Lys-Pro), its cleaved AcSDKP sequence is an **autonomous angiogenic factor**, it upregulates laminin-5 and matrix metalloproteinases (MMPs), and mobilizes mesenchymal progenitor cells
Once you've punctured the stopper and drawn your first dose, the vial goes into the fridge at 28C (3646F)
Typical Clinical Ranges Loading Phase: 25 mg per week (subcutaneous injection) for 46 weeks Maintenance Phase: 2 mg every 12 weeks after the loading period Key Considerations Personalization: Dosage should be adjusted based on individual symptoms, sensitivities, and treatment response
Then the vial arrives and it is pink
BPC-157 is a synthetic 15-amino-acid pentadecapeptide derived from a gastric body protection compound, studied mainly for tendon, muscle, and gut healing in rodents